SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 68 filers reported holding SOLENO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,675,000 | -20.4% | 9,436,512 | 0.0% | 0.08% | -9.7% |
| Q1 2022 | $2,104,000 | -47.5% | 9,436,512 | -3.4% | 0.09% | -34.0% |
| Q4 2021 | $4,004,000 | -55.6% | 9,765,129 | 0.0% | 0.14% | -50.5% |
| Q3 2021 | $9,028,000 | -18.9% | 9,765,129 | 0.0% | 0.28% | -9.8% |
| Q2 2021 | $11,132,000 | +13.0% | 9,765,129 | +24.9% | 0.32% | +9.7% |
| Q1 2021 | $9,849,000 | -35.2% | 7,816,729 | -0.7% | 0.29% | -38.9% |
| Q4 2020 | $15,192,000 | -18.5% | 7,871,356 | +6.0% | 0.47% | -17.4% |
| Q3 2020 | $18,640,000 | +13.1% | 7,426,368 | 0.0% | 0.57% | +14.7% |
| Q2 2020 | $16,487,000 | +61.9% | 7,426,368 | +73.6% | 0.50% | +30.4% |
| Q1 2020 | $10,181,000 | -19.1% | 4,277,923 | 0.0% | 0.38% | -1.6% |
| Q4 2019 | $12,577,000 | – | 4,277,923 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 10,302,602 | $9,500,000 | 2.16% |
| Nantahala Capital Management | 9,765,129 | $9,028,000 | 0.28% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,132,000 | $1,971,000 | 0.24% |
| Granite Point Capital Management, L.P. | 701,838 | $649,000 | 0.05% |
| OPPENHEIMER & CO INC | 639,140 | $591,000 | 0.01% |
| Ikarian Capital, LLC | 121,694 | $112,000 | 0.01% |
| Warberg Asset Management LLC | 30,000 | $28,000 | 0.01% |
| Levy Wealth Management Group, LLC | 10,000 | $9,000 | 0.01% |
| Ergoteles LLC | 74,525 | $69,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 744,000 | $688,000 | 0.00% |